DFCI ALL Consortium Trial: Pegylated Asparaginase Pediatric Regimen in Adults with Untreated ALL


DFCI ALL Consortium Trial: Pegylated Asparaginase Pediatric Regimen in Adults with Untreated ALL
Slides from a presentation at ASH 2015 and transcribed comments from a recent interview with Richard M Stone, MD (2/16/16)

DeAngelo DJ et al. A multicenter Phase II study using a dose intensified pegylated-asparaginase pediatric regimen in adults with untreated acute lymphoblastic leukemia: A DFCI ALL Consortium trial. Proc ASH 2015;Abstract 80.

Dr Stone is Director of the Adult Leukemia Program at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School in Boston, Massachusetts.